blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1427391

EP1427391 - SOLID-PHASE AGENT FOR VASCULAR OCCLUSION WITH IMMOBILISED PLATELET BINDING AGENT [Right-click to bookmark this link]
Former [2004/25]VASCULAR OCCLUSION SOLID-PHASE AGENT WITH IMMOBILISED PLATELET BINDING AGENT
[2008/28]
StatusNo opposition filed within time limit
Status updated on  15.05.2009
Database last updated on 16.11.2024
Most recent event   Tooltip29.10.2010Lapse of the patent in a contracting state
New state(s): GR
published on 01.12.2010  [2010/48]
Applicant(s)For all designated states
ViRexx Medical Corporation
1500, 10180-101 Street
Edmonton, Alberta T5J 4KI / CA
[2008/28]
Former [2004/46]For all designated states
ViRexx Medical Corporation
1500, 10180-101 Streeter Avenue
Edmonton, Alberta T5J 4K1 / CA
Former [2004/34]For all designated states
ViRexx Medical Corporation
1500, 10180-101 Streeter Avenue
Edmonton, Alberta T5J 4K1 / CA
For all designated states
Stewart, Michael W.
6 Laurent Place
St. Albert, Alberta T6G 2J3 / CA
For all designated states
Person, Roland Henryk
12407 28A Avenue
Edmonton, Alberta T6J 4L5 / CA
For all designated states
Noujaim, Antoine A.
58 Wilkins Road
Edmonton, Alberta T6M 2K4 / CA
Former [2004/25]For all designated states
Virexx Research, Inc.
Suite 2C30, 11111 Jasper Avenue
Edmonton, Alberta T5K 0L4 / CA
For all designated states
Stewart, Michael W.
6 Laurent Place
St. Albert, Alberta T6G 2J3 / CA
For all designated states
Person, Roland Henryk
12407 28A Avenue
Edmonton, Alberta T6J 4L5 / CA
For all designated states
Noujaim, Antoine A.
58 Wilkins Road
Edmonton, Alberta T6M 2K4 / CA
Inventor(s)01 / STEWART, Michael, W.
6 Laurent Place
St. Albert, Alberta T6G 2J3 / CA
02 / PERSON, Roland, Henryk
12407 28A Avenue
Edmonton, Alberta T6J 4L5 / CA
03 / NOUJAIM, Antoine, A.
58 Wilkins Road
Edmonton, Alberta T6M 2K4 / CA
 [2004/25]
Representative(s)Gates, Marie Christina Esther, et al
Tomkins & Co.
5 Dartmouth Road
Dublin 6 / IE
[N/P]
Former [2004/29]Gates, Marie Christina Esther, et al
Tomkins & Co. 5 Dartmouth Road
Dublin 6 / IE
Former [2004/25]Lane, Cathal Michael, et al
c/o Tomkins & Co. 5 Dartmouth Road
Dublin 6 / IE
Application number, filing date02798013.511.09.2002
[2004/25]
WO2002IB03674
Priority number, dateUS20010318339P12.09.2001         Original published format: US 318339 P
[2004/25]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO03022244
Date:20.03.2003
Language:EN
[2003/12]
Type: A1 Application with search report 
No.:EP1427391
Date:16.06.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 20.03.2003 takes the place of the publication of the European patent application.
[2004/25]
Type: B1 Patent specification 
No.:EP1427391
Date:09.07.2008
Language:EN
[2008/28]
Search report(s)International search report - published on:EP20.03.2003
ClassificationIPC:A61K9/00, A61K9/16, A61K38/36, A61K47/48, A61L31/16, A61P35/00
[2004/25]
CPC:
A61L24/108 (EP,US); A61K9/16 (KR); A61K31/16 (EP,US);
A61K38/36 (EP,KR,US); A61K38/37 (EP,US); A61K47/50 (KR);
A61K47/62 (EP,US); A61K47/6921 (EP,US); A61K47/6927 (EP,US);
A61K9/167 (EP,US); A61L31/047 (EP,US); A61L31/16 (EP,US);
A61P35/00 (EP); A61L2300/252 (EP,US); A61L2300/418 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SK,   TR [2004/25]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:FESTPHASENMITTEL ZUR VASKULÄREN OKKLUSION MIT IMMOBILISIERTER THROMBOZYTEN-BINDUNGSSUBSTANZ[2008/28]
English:SOLID-PHASE AGENT FOR VASCULAR OCCLUSION WITH IMMOBILISED PLATELET BINDING AGENT[2008/28]
French:AGENT DE PHASE SOLIDE D'OCCLUSION VASCULAIRE ASSOCIE A UN AGENT DE LIAISON PLAQUETTAIRE IMMOBILISE[2008/28]
Former [2004/25]VASKULÄRE OKKLUSION DURCH FEST-PHASEN SUBSTANZ MIT IMMOBILISIERTER THROMBOZYTEN-BINDUNGSSUBSTANZ
Former [2004/25]VASCULAR OCCLUSION SOLID-PHASE AGENT WITH IMMOBILISED PLATELET BINDING AGENT
Former [2004/25]AGENT D'OCCLUSION VASCULAIRE EN PHASE SOLIDE ASSOCIE A UN AGENT DE LIAISON PLAQUETTAIRE IMMOBILISE
Entry into regional phase08.04.2004National basic fee paid 
08.04.2004Designation fee(s) paid 
08.04.2004Examination fee paid 
Examination procedure31.03.2003Request for preliminary examination filed
International Preliminary Examining Authority: EP
08.04.2004Amendment by applicant (claims and/or description)
08.04.2004Examination requested  [2004/25]
15.02.2005Despatch of a communication from the examining division (Time limit: M04)
21.06.2005Reply to a communication from the examining division
04.08.2005Despatch of a communication from the examining division (Time limit: M06)
23.12.2005Reply to a communication from the examining division
11.06.2007Despatch of a communication from the examining division (Time limit: M02)
03.08.2007Reply to a communication from the examining division
19.11.2007Communication of intention to grant the patent
14.03.2008Fee for grant paid
14.03.2008Fee for publishing/printing paid
Divisional application(s)EP08159959.9  / EP2005944
Opposition(s)14.04.2009No opposition filed within time limit [2009/25]
Fees paidRenewal fee
08.09.2004Renewal fee patent year 03
14.09.2005Renewal fee patent year 04
21.09.2006Renewal fee patent year 05
18.09.2007Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT09.07.2008
BE09.07.2008
CY09.07.2008
CZ09.07.2008
DK09.07.2008
EE09.07.2008
FI09.07.2008
IT09.07.2008
NL09.07.2008
SK09.07.2008
TR09.07.2008
LU11.09.2008
MC30.09.2008
BG09.10.2008
SE09.10.2008
GR10.10.2008
ES20.10.2008
PT09.12.2008
[2010/48]
Former [2010/37]AT09.07.2008
BE09.07.2008
CY09.07.2008
CZ09.07.2008
DK09.07.2008
EE09.07.2008
FI09.07.2008
IT09.07.2008
NL09.07.2008
SK09.07.2008
TR09.07.2008
LU11.09.2008
MC30.09.2008
BG09.10.2008
SE09.10.2008
ES20.10.2008
PT09.12.2008
Former [2010/34]AT09.07.2008
BE09.07.2008
CY09.07.2008
CZ09.07.2008
DK09.07.2008
EE09.07.2008
FI09.07.2008
IT09.07.2008
NL09.07.2008
SK09.07.2008
LU11.09.2008
MC30.09.2008
BG09.10.2008
SE09.10.2008
ES20.10.2008
PT09.12.2008
Former [2010/32]AT09.07.2008
BE09.07.2008
CZ09.07.2008
DK09.07.2008
EE09.07.2008
FI09.07.2008
IT09.07.2008
NL09.07.2008
SK09.07.2008
LU11.09.2008
MC30.09.2008
BG09.10.2008
SE09.10.2008
ES20.10.2008
PT09.12.2008
Former [2010/09]AT09.07.2008
BE09.07.2008
CZ09.07.2008
DK09.07.2008
EE09.07.2008
FI09.07.2008
IT09.07.2008
NL09.07.2008
SK09.07.2008
MC30.09.2008
BG09.10.2008
SE09.10.2008
ES20.10.2008
PT09.12.2008
Former [2009/39]AT09.07.2008
BE09.07.2008
CZ09.07.2008
DK09.07.2008
EE09.07.2008
FI09.07.2008
IT09.07.2008
NL09.07.2008
SK09.07.2008
MC30.09.2008
BG09.10.2008
ES20.10.2008
PT09.12.2008
Former [2009/24]AT09.07.2008
BE09.07.2008
CZ09.07.2008
DK09.07.2008
EE09.07.2008
FI09.07.2008
NL09.07.2008
SK09.07.2008
MC30.09.2008
BG09.10.2008
ES20.10.2008
PT09.12.2008
Former [2009/22]AT09.07.2008
BE09.07.2008
DK09.07.2008
EE09.07.2008
FI09.07.2008
NL09.07.2008
MC30.09.2008
BG09.10.2008
ES20.10.2008
PT09.12.2008
Former [2009/20]AT09.07.2008
BE09.07.2008
DK09.07.2008
FI09.07.2008
NL09.07.2008
MC30.09.2008
BG09.10.2008
ES20.10.2008
PT09.12.2008
Former [2009/19]AT09.07.2008
BE09.07.2008
DK09.07.2008
FI09.07.2008
NL09.07.2008
BG09.10.2008
ES20.10.2008
PT09.12.2008
Former [2009/14]AT09.07.2008
FI09.07.2008
NL09.07.2008
BG09.10.2008
ES20.10.2008
PT09.12.2008
Former [2009/12]FI09.07.2008
NL09.07.2008
BG09.10.2008
ES20.10.2008
PT09.12.2008
Former [2009/09]NL09.07.2008
ES20.10.2008
PT09.12.2008
Cited inInternational search[A]WO0029029  (NOVOLYTICS INC [CA], et al) [A] 1-35 * page 1, line 9 - line 15 * * page 28, line 12 * * examples 3,4,7 ** claims 1-6,8 *;
 [PX]  - JURASZ PAUL ET AL, "Role of von Willebrand factor in tumour cell-induced platelet aggregation: Differential regulation by NO and prostacyclin.", BRITISH JOURNAL OF PHARMACOLOGY, (200111), vol. 134, no. 5, ISSN 0007-1188, pages 1104 - 1112, XP009003265 [PX] 1-35 * the whole document *

DOI:   http://dx.doi.org/10.1038/sj.bjp.0704343
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.